| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ronald J. Tallarida | Q38360335 |
| P2860 | cites work | Interaction between drugs using three-dimensional isobolographic interpretation | Q46275747 |
| Interaction between pentobarbital and decreased calcium ion on guinea pig atria | Q46812353 | ||
| Approaches to the study of drug interactions in behavioral pharmacology | Q48415927 | ||
| Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat. | Q48559182 | ||
| Additive effects of anesthetics and theories of anesthesia. | Q52736179 | ||
| Evidence for a synergistic interaction between phenytoin and phenobarbital in experimental animals | Q52737240 | ||
| Pharmacological effects of a combination of butorphanol and acetaminophen | Q67435003 | ||
| Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine | Q71851330 | ||
| The problem of synergism and antagonism of combined drugs | Q73248616 | ||
| Discovery of "self-synergistic" spinal/supraspinal antinociception produced by acetaminophen (paracetamol) | Q74326733 | ||
| Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice | Q28165249 | ||
| Pharmacological characterization of muscarinic receptors in mouse isolated urinary bladder smooth muscle | Q28345453 | ||
| Some quantitative uses of drug antagonists | Q29616831 | ||
| N-methyl-D-aspartate antagonists and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a cannabinoid agonist, interact to produce synergistic hypothermia | Q34149812 | ||
| Drug synergism: its detection and applications | Q34337018 | ||
| Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol | Q34344047 | ||
| Statistical analysis of drug combinations for synergism | Q36155427 | ||
| An overview of drug combination analysis with isobolograms | Q36466884 | ||
| What is synergy? | Q38752149 | ||
| pA2 and receptor differentiation: a statistical analysis of competitive antagonism | Q39813802 | ||
| Commentary on neostigmine interactions with non steroidal anti-inflammatory drugs by Miranda et al. | Q41768071 | ||
| pA, a new scale for the measurement of drug antagonism | Q42367410 | ||
| Neostigmine interactions with non steroidal anti-inflammatory drugs | Q43263827 | ||
| The interaction index: a measure of drug synergism | Q44050835 | ||
| Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes | Q44186035 | ||
| Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain | Q44186088 | ||
| Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity | Q44330959 | ||
| A study of the interaction of the hypnotic effects and of the toxic effects of chloral hydrate and ethanol. | Q44382136 | ||
| Isobolographic analysis for combinations of a full and partial agonist: curved isoboles | Q44919630 | ||
| Estimation of apparent agonist affinity constants using desensitization of the ileal muscarinic receptor. | Q46186294 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 197-209 | |
| P577 | publication date | 2006-09-07 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | Interactions between drugs and occupied receptors | |
| P478 | volume | 113 |
| Q30436689 | A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation |
| Q45765749 | A search for interaction among combinations of drugs of abuse and the use of isobolographic analysis |
| Q38503401 | Acetaminophen (paracetamol) oral absorption and clinical influences |
| Q35175618 | Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain |
| Q33580906 | An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines |
| Q35845089 | Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis |
| Q37878206 | Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update |
| Q28575056 | Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain |
| Q37782343 | Chemotherapy-Related Visual System Toxicity |
| Q42368628 | Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling |
| Q36729413 | Cocaine synergism with α agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition |
| Q37782346 | Combination Analysis |
| Q42548830 | Combination Drug Therapy for Pain following Chronic Spinal Cord Injury |
| Q39089137 | Combination studies of platinum(II)-based metallointercalators with buthionine-S,R-sulfoximine, 3-bromopyruvate, cisplatin or carboplatin |
| Q34984055 | Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity |
| Q35923194 | Combinations of intrathecal gamma-amino-butyrate receptor agonists and N-methyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain |
| Q37890040 | Continuous multimechanistic postoperative analgesia: a rationale for transitioning from intravenous acetaminophen and opioids to oral formulations |
| Q37709569 | Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. |
| Q34321724 | Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity |
| Q40907848 | Drug interaction: focusing on response surface models |
| Q35645883 | Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced ‘chemo-fog’ |
| Q38307252 | Environmentally oriented models and methods for the evaluation of drug × drug interaction effects. |
| Q33560467 | Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain |
| Q42328146 | Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer Cells |
| Q51525907 | In silico synergism and antagonism of an anti-tumour system intervened by coupling immunotherapy and chemotherapy: a mathematical modelling approach. |
| Q46529490 | Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves |
| Q37545100 | Isobolographic analysis demonstrates additive effect of cisplatin and HDIs combined treatment augmenting their anti-cancer activity in lung cancer cell lines. |
| Q48255546 | Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: a practical application |
| Q46387953 | Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model. |
| Q46260479 | Material basis for inhibition of Dragon's Blood on evoked discharges of wide dynamic range neurons in spinal dorsal horn of rats |
| Q83265745 | Mechanisms of drug combinations: interaction and network perspectives |
| Q42355202 | Nonlinear response surface in the study of interaction analysis of three combination drugs |
| Q53801904 | Novel agonist of adenosine receptor induces relaxation of corpus cavernosum in guinea pigs: an in vitro and in vivo study. |
| Q33522859 | On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data |
| Q39227660 | On the quantitation of an agonist with dual but opposing components of action: application to vascular endothelial relaxation |
| Q33713626 | Oxycodone combinations for pain relief. |
| Q28396233 | Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive |
| Q34981070 | Principles of laboratory assessment of drug abuse liability and implications for clinical development |
| Q38022020 | Quantitative methods for assessing drug synergism |
| Q36057956 | Revisiting the isobole and related quantitative methods for assessing drug synergism |
| Q34256805 | Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics |
| Q37154206 | Self-administration of cocaine-remifentanil mixtures by monkeys: an isobolographic analysis |
| Q36495153 | Synergistic depression of NMDA receptor-mediated transmission by ketamine, ketoprofen and L-NAME combinations in neonatal rat spinal cords in vitro |
| Q52574407 | Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats. |
| Q46742573 | Synergistic interaction between diene valepotriates from Valeriana glechomifolia Meyer (Valerianaceae) and classical antidepressants: an isobolographic analysis |
| Q42182000 | Synergistic interaction between the two mechanisms of action of tapentadol in analgesia |
| Q39314422 | Synergistic interaction of gabapentin with tiagabine in the formalin test in mice: an isobolographic analysis |
| Q34628322 | Tapentadol in pain management: a μ-opioid receptor agonist and noradrenaline reuptake inhibitor |
| Q37764985 | The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations |
| Q37719166 | The determination and application of fixed-dose analgesic combinations for treating multimodal pain |
| Q45234525 | The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. |
| Q46127224 | The synergistic interaction between rilmenidine and paracetamol in the writhing test in mice |
| Q35751766 | The use of occupation isoboles for analysis of a response mediated by two receptors: M2 and M3 muscarinic receptor subtype-induced mouse stomach contractions |
| Q41226219 | Theory of synergistic effects: Hill-type response surfaces as 'null-interaction' models for mixtures |
| Q36235082 | Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain |
| Q26770477 | Two drugs are better than one. A short history of combined therapy of ovarian cancer |
| Q38065010 | Understanding synergy |
| Q34939720 | μ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons |
Search more.